Osteosarcoma cells induce endothelial cell proliferation during neo-angiogenesis

Journal of Cellular Physiology

Volumn 228, Issue 4, 2013, Pages 846-852

  de Nigris, Filomena ^a   Mancini, Francesco Paolo ^b   Schiano, Concetta ^a   Infante, Teresa ^c   Zullo, Alberto ^b   Minucci, Pellegrino Biagio ^a   Al Omran, Mohammed ^d   Giordano, Antonio ^e,f   Napoli, Claudio ^a,c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF SANNIO   (Italy)

^c IRCCS SDN   (Italy)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e UNIVERSITY OF SIENA   (Italy)

^f Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 5; ROSCOVITINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTINEOPLASTIC AGENTS; AORTA; APOPTOSIS; BONE NEOPLASMS; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIA; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 5; ENDOTHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; PURINES; UP-REGULATION; YY1 TRANSCRIPTION FACTOR;

EID: 84871685704     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24234     Document Type: Article

References (32)

1. Affar El B, Gay F, Shi Y, Liu H, Huarte M, Wu S, Collins T, Li E, Shi Y. 2006. Essential dosage-dependent functions of the transcription factor Yin Yang 1 in late embryonic development and cell cycle progression. Mol Cell Biol 26:3565-3581.
2. Appleyard MV, O'Neill MA, Murray KE, Paulin FE, Bray SE, Kernohan NM, Levison DA, Lane DP, Thompson AM. 2009. Seliciclib (CYC202, R-Roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model. Int J Cancer 124:465-472.
3. Bussolino F, Mantovani A, Persico G. 1997. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22:251-256.
4. Castellano G, Torrisi E, Ligresti G, Malaponte G, Militello L, Russo AE, McCubrey JA, Canevari S, Libra M. 2009. The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle 8:1367-1372.
5. Chaudhary A, St Croix B. 2012. Selective blockade of tumor angiogenesis. Cell Cycle 11:2253-2259.
6. Crescenzi E, Palumbo G, Brady HJ. 2005. Roscovitine modulates DNA repair and senescence: Implications for combination chemotherapy. Clin Cancer Res 11:8158-8171.
7. de Nigris F, Botti C, de Chiara A, Rossiello R, Apice G, Fazioli F, Fiorito C, Sica V, Napoli C. 2006. Expression of transcription factor Yin Yang 1 in human osteosarcomas. Eur J Cancer 42:2420-2424.
8. de Nigris F, Botti C, Rossiello R, Crimi E, Sica V, Napoli C. 2007. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene 26:382-394.
9. de Nigris F, Rossiello R, Schiano C, Arra C, Williams-Ignarro S, Barbieri A, Lanza A, Balestrieri A, Giuliano MT, Ignarro LJ, Napoli C. 2008. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. Cancer Res 68:1797-1808.
10. de Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, Cacciatore F, Pentimalli F, Marquez-Garban DC, Petrillo A, Cito L, Sommese L, Fiore A, Petrillo M, Siani A, Barbieri A, Arra C, Rengo F, Hayashi T, Al-Omran M, Ignarro LJ, Napoli C. 2010. CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci U S A 107:14484-14489.
11. de Nigris F, Zanella L, Cacciatore F, De Chiara A, Fazioli F, Chiappetta G, Apice G, Infante T, Monaco M, Rossiello R, De Rosa G, Alberghini M, Napoli C. 2011. YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma. BMC Cancer 11:472.
12. Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y. 1999. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol 19:7237-7244.
13. Folkman J. 1997. Addressing tumour blood vessels. Nat Biotechnol 15:510.
14. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
15. Gordon S, Akopyan G, Garban H, Bonavida B. 2006. Transcription factor YY1: Structure, function and therapeutic implications in cancer biology. Oncogene 25:1125-1142.
16. Hanahan D, Folkman J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
17. He Y, Sandoval J, Casaccia-Bonnefil P. 2007. Events at the transition between cell cycle exit and oligodendrocyte progenitor differentiation: The role of HDAC and YY1. Neuron Glia Biol 3:221-231.
18. Jin YJ, Lee JH, Kim YM, Oh GT, Lee H. 2012. Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways. Cell Signal 8:1485-1495.
19. Kitayoshi M, Kato K, Tanabe E, Yoshikawa K, Fukui R, Fukushima N, Tsujiuchi T. 2012. Enhancement of endothelial cell migration by constitutively active LPA(1)-expressing tumor cells. Biochem Biophys Res Commun 422:339-343.
20. Lambert LA, Qiao N, Hunt KK, Lambert DH, Mills GB, Meijer L, Keyomarsi K. 2008. Autophagy: A novel mechanism of synergistic cytotoxicity between doxorubicin and Roscovitine in a sarcoma model. Cancer Res 68:7966-7974.
21. Liebl J, Weitensteiner SB, Vereb G, Takács L, Fürst R, Vollmar AM, Zahler S. 2010. Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis. J Biol Chem 285:35932-35943.
22. Liebl J, Krystof V, Vereb G, Takács L, Strnad M, Pechan P, Havlicek L, Zatloukal M, Fürst R, Vollmar AM, Zahler S. 2011. Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases. Angiogenesis 3:281-291.
23. Maggiorella L, Aubel C, Haton C, Milliat F, Connault E, Opolon P, Deutsch E, Bourhis J. 2009. Cooperative effect of Roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma. Cell Prolif 42:38-48.
24. Napoli C, Giordano A, Casamassimi A, Pentimalli F, Ignarro LJ, De Nigris F. 2011. Directed in vivo angiogenesis assay and the study of systemic neoangiogenesis in cancer. Int J Cancer 128:1505-1508.
25. Park AY, Shen TL, Chien S, Guan JL. 2009. Role of focal adhesion kinase Ser-732 phosphorylation in centrosome function during mitosis. J Biol Chem 284:9418-9425.
26. Shapiro GI. 2006. Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24:1770-1783.
27. Shi Y, Lee JS, Galvin KM. 1997. Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta 1332:F49-F66.
28. Taylor SM, Nevis KR, Park HL, Rogers GC, Rogers SL, Cook JG, Bautch VL. 2010. Angiogenic factor signalling regulates centrosome duplication in endothelial cells of developing blood vessels. Blood 116:3108-3117.
29. Tripathi BK, Zelenka PS. 2009. Cdk5-dependent regulation of Rho activity, cytoskeletal contraction, and epithelial cell migration via suppression of Src and p190RhoGAP. Mol Cell Biol 29:6488-6499.
30. Weed SA, Parsons JT. 2001. Cortactin: Coupling membrane dynamics to cortical actin assembly. Oncogene 20:6418-6434.
31. Wilkinson FH, Park K, Atchison ML. 2006. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc Natl Acad Sci U S A 103:19296-19301.
32. Yang CL, Liu YY, Ma YG, Xue YX, Liu DG, Ren Y, Liu XB, Li Y, Li Z. 2012. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS ONE 7:e37960.